Cargando…

Fractional dynamics pharmacokinetics–pharmacodynamic models

While an increasing number of fractional order integrals and differential equations applications have been reported in the physics, signal processing, engineering and bioengineering literatures, little attention has been paid to this class of models in the pharmacokinetics–pharmacodynamic (PKPD) lit...

Descripción completa

Detalles Bibliográficos
Autor principal: Verotta, Davide
Formato: Texto
Lenguaje:English
Publicado: Springer US 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2889283/
https://www.ncbi.nlm.nih.gov/pubmed/20455076
http://dx.doi.org/10.1007/s10928-010-9159-z
_version_ 1782182684198436864
author Verotta, Davide
author_facet Verotta, Davide
author_sort Verotta, Davide
collection PubMed
description While an increasing number of fractional order integrals and differential equations applications have been reported in the physics, signal processing, engineering and bioengineering literatures, little attention has been paid to this class of models in the pharmacokinetics–pharmacodynamic (PKPD) literature. One of the reasons is computational: while the analytical solution of fractional differential equations is available in special cases, it this turns out that even the simplest PKPD models that can be constructed using fractional calculus do not allow an analytical solution. In this paper, we first introduce new families of PKPD models incorporating fractional order integrals and differential equations, and, second, exemplify and investigate their qualitative behavior. The families represent extensions of frequently used PK link and PD direct and indirect action models, using the tools of fractional calculus. In addition the PD models can be a function of a variable, the active drug, which can smoothly transition from concentration to exposure, to hyper-exposure, according to a fractional integral transformation. To investigate the behavior of the models we propose, we implement numerical algorithms for fractional integration and for the numerical solution of a system of fractional differential equations. For simplicity, in our investigation we concentrate on the pharmacodynamic side of the models, assuming standard (integer order) pharmacokinetics.
format Text
id pubmed-2889283
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-28892832010-07-12 Fractional dynamics pharmacokinetics–pharmacodynamic models Verotta, Davide J Pharmacokinet Pharmacodyn Article While an increasing number of fractional order integrals and differential equations applications have been reported in the physics, signal processing, engineering and bioengineering literatures, little attention has been paid to this class of models in the pharmacokinetics–pharmacodynamic (PKPD) literature. One of the reasons is computational: while the analytical solution of fractional differential equations is available in special cases, it this turns out that even the simplest PKPD models that can be constructed using fractional calculus do not allow an analytical solution. In this paper, we first introduce new families of PKPD models incorporating fractional order integrals and differential equations, and, second, exemplify and investigate their qualitative behavior. The families represent extensions of frequently used PK link and PD direct and indirect action models, using the tools of fractional calculus. In addition the PD models can be a function of a variable, the active drug, which can smoothly transition from concentration to exposure, to hyper-exposure, according to a fractional integral transformation. To investigate the behavior of the models we propose, we implement numerical algorithms for fractional integration and for the numerical solution of a system of fractional differential equations. For simplicity, in our investigation we concentrate on the pharmacodynamic side of the models, assuming standard (integer order) pharmacokinetics. Springer US 2010-05-09 2010 /pmc/articles/PMC2889283/ /pubmed/20455076 http://dx.doi.org/10.1007/s10928-010-9159-z Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Article
Verotta, Davide
Fractional dynamics pharmacokinetics–pharmacodynamic models
title Fractional dynamics pharmacokinetics–pharmacodynamic models
title_full Fractional dynamics pharmacokinetics–pharmacodynamic models
title_fullStr Fractional dynamics pharmacokinetics–pharmacodynamic models
title_full_unstemmed Fractional dynamics pharmacokinetics–pharmacodynamic models
title_short Fractional dynamics pharmacokinetics–pharmacodynamic models
title_sort fractional dynamics pharmacokinetics–pharmacodynamic models
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2889283/
https://www.ncbi.nlm.nih.gov/pubmed/20455076
http://dx.doi.org/10.1007/s10928-010-9159-z
work_keys_str_mv AT verottadavide fractionaldynamicspharmacokineticspharmacodynamicmodels